참고문헌
- National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. https://doi.org/10.1056/NEJMoa1102873
- Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920-31. https://doi.org/10.1056/NEJMoa1208962
- Kim D, Kim HK, Kim SH, et al. Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer. J Thorac Dis 2018;10:388-97. https://doi.org/10.21037/jtd.2017.12.38
- Berry MF, Gao R, Kunder CA, et al. Presence of even a small ground-glass component in lung adenocarcinoma predicts better survival. Clin Lung Cancer 2018;19:e47-51. https://doi.org/10.1016/j.cllc.2017.06.020
- Travis WD, Asamura H, Bankier AA, et al. The IASLC Lung Cancer Staging Project: proposals for coding t categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2016;11:1204-23. https://doi.org/10.1016/j.jtho.2016.03.025
- Noguchi M. Stepwise progression of pulmonary adenocarcinoma: clinical and molecular implications. Cancer Metastasis Rev 2010;29:15-21. https://doi.org/10.1007/s10555-010-9210-y
- Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 2015;10:1243-60. https://doi.org/10.1097/jto.0000000000000630
- Jamal-Hanjani M, Wilson GA, McGranahan N, et al. Tracking the evolution of non-small-cell lung cancer. N Engl J Med 2017;376:2109-21. https://doi.org/10.1056/NEJMoa1616288
- Sakamoto H, Shimizu J, Horio Y, et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol 2007;212:287-94. https://doi.org/10.1002/path.2165
- Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51. https://doi.org/10.1016/j.jtho.2015.09.009
- Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009;27:182-9. https://doi.org/10.1038/nbt.1523
- Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics 2015;16:169. https://doi.org/10.1186/s12859-015-0611-3
- Devarakonda S, Rotolo F, Tsao MS, et al. Tumor mutation burden as a biomarker in resected non-small-cell lung cancer. J Clin Oncol 2018;36:2995-3006. https://doi.org/10.1200/JCO.2018.78.1963
- Xiong L, Wen Y, Miao X, Yang Z. NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer. Cell Tissue Res 2014;355:365-74. https://doi.org/10.1007/s00441-013-1752-1
- Silveyra P, Floros J. Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2. Gene 2013;531:126-32. https://doi.org/10.1016/j.gene.2012.09.111
- Peng L, Bian XW, Li DK, et al. Large-scale RNA-Seq transcriptome analysis of 4043 cancers and 548 normal tissue controls across 12 TCGA cancer types. Sci Rep 2015;5:13413. https://doi.org/10.1038/srep13413
- Xiao W, Gao Z, Duan Y, Yuan W, Ke Y. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma. J Exp Clin Cancer Res 2017;36:41. https://doi.org/10.1186/s13046-017-0507-3
- Hellmann MD, Ciuleanu TE, Pluzanski A, et al. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden. N Engl J Med 2018;378:2093-104. https://doi.org/10.1056/NEJMoa1801946
-
Du L, Yamamoto S, Burnette BL, et al. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of
$TGF{\beta}$ -induced epithelial-to-mesenchymal transition. Cancer Med 2016;5:1962-72. https://doi.org/10.1002/cam4.719 - Feng J, Zhang X, Zhu H, Wang X, Ni S, Huang J. FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS One 2012;7:e39937. https://doi.org/10.1371/journal.pone.0039937
- Sebastian M, Papachristofilou A, Weiss C, et al. Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive(R)) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer. BMC Cancer 2014;14:748. https://doi.org/10.1186/1471-2407-14-748
- Qiu L, Tan X, Lin J, et al. CDC27 induces metastasis and invasion in colorectal cancer via the promotion of epithelial-to-mesenchymal transition. J Cancer 2017;8:2626-35. https://doi.org/10.7150/jca.19381
- Xin Y, Ning S, Zhang L, Cui M. CDC27 facilitates gastric cancer cell proliferation, invasion and metastasis via twist-induced epithelial- mesenchymal transition. Cell Physiol Biochem 2018;50:501-11. https://doi.org/10.1159/000494164
- Wang Y, Yang R, Wang X, et al. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer. Medicine (Baltimore) 2018;97:e13817. https://doi.org/10.1097/md.0000000000013817
- Yang Y, Yang Y, Zhou X, et al. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity. Lung Cancer 2015;87:272-7. https://doi.org/10.1016/j.lungcan.2014.12.016
- Mao W, Wen Y, Lei H, et al. Isolation and retrieval of extracellular vesicles for liquid biopsy of malignant ground-glass opacity. Anal Chem 2019;91:13729-36. https://doi.org/10.1021/acs.analchem.9b03064